{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:27:34Z","timestamp":1794695254699,"version":"4.9.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3]]},"abstract":"<jats:p>Cell-free DNA screening for fetal aneuploidy is a commonly used testing strategy in pregnancies at high risk for fetal aneuploidy. The use of cell-free DNA screening is expanding to the low-risk population, because the detection rate for trisomy 21 surpasses that of traditional screening modalities. Although the sensitivity and specificity of cell-free DNA are superior to traditional screening, false-positive results do occur and may indicate an adverse maternal health condition, including maternal mosaicism or, rarely, malignancy. The risk of maternal cancer is significantly elevated when more than one aneuploidy is detected that is discordant from fetal karyotype. Given this risk as well as the rising incidence of cancer in pregnancy, patient counseling and malignancy evaluation should be considered in women when more than one aneuploidy is detected. We reviewed the published literature and developed an algorithm to evaluate women when these results are identified.<\/jats:p>","DOI":"10.1097\/aog.0000000000002474","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T14:58:39Z","timestamp":1518101919000},"page":"464-468","source":"Crossref","is-referenced-by-count":40,"title":["Maternal Malignancy Evaluation After Discordant Cell-Free DNA Results"],"prefix":"10.1097","volume":"131","author":[{"given":"Laura M.","family":"Carlson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Coombs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta L.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.clinbiochem.2015.02.011","article-title":"Cell-free DNA screening for fetal aneuploidy as a clinical service","volume":"48","author":"Cuckle","year":"2015","journal-title":"Clin Biochem"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2015.7120","article-title":"Noninvasive prenatal testing and incidental detection of occult maternal malignancies","volume":"314","author":"Bianchi","year":"2015","journal-title":"JAMA"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pd.4778","article-title":"Follow-up of multiple aneuploidies and single monosomies detected by noninvasive prenatal testing: implications for management and counseling","volume":"36","author":"Snyder","year":"2016","journal-title":"Prenat Diagn"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamaoncol.2015.1883","article-title":"Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing","volume":"1","author":"Amant","year":"2015","journal-title":"JAMA Oncol"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"Cell-free DNA screening for fetal aneuploidy. Committee Opinion No. 640. American College of Obstetricians and Gynecologists","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/gim.2016.97","article-title":"Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics","volume":"18","author":"Gregg","year":"2016","journal-title":"Genet Med"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21387","article-title":"Cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/OGX.0000000000000068","article-title":"Cancer and pregnancy: the clinician's perspective","volume":"69","author":"Dotters-Katz","year":"2014","journal-title":"Obstet Gynecol Surv"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ejca.2005.10.014","article-title":"Cancer and pregnancy: poena magna, not anymore","volume":"42","author":"Pentheroudakis","year":"2006","journal-title":"Eur J Cancer"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1067\/mob.2001.114867","article-title":"Obstetrical deliveries associated with maternal malignancy in California, 1992 through 1997","volume":"184","author":"Smith","year":"2001","journal-title":"Am J Obstet Gynecol"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2012.45.2011","article-title":"Liquid biopsies: genotyping circulating tumor DNA","volume":"32","author":"Diaz","year":"2014","journal-title":"J Clin Oncol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.lungcan.2016.06.013","article-title":"The diagnostic value of circulating cell free DNA quantification in non-small cell lung cancer: a systematic review with meta-analysis","volume":"100","author":"Jiang","year":"2016","journal-title":"Lung Cancer"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/ng.2270","article-title":"Detectable clonal mosaicism and its relationship to aging and cancer","volume":"44","author":"Jacobs","year":"2012","journal-title":"Nat Genet"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/ng.2271","article-title":"Detectable clonal mosaicism from birth to old age and its relationship to cancer","volume":"44","author":"Laurie","year":"2012","journal-title":"Nat Genet"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1001\/jama.2016.6828","article-title":"Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US Preventive Services Task Force","volume":"315","author":"Knudsen","year":"2016","journal-title":"JAMA"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2016.12126","article-title":"Association between MRI exposure during pregnancy and fetal and childhood outcomes","volume":"316","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2214\/AJR.14.13663","article-title":"Diagnostic performance of whole-body MRI as a tool for cancer screening in children with genetic cancer-predisposing conditions","volume":"205","author":"Anupindi","year":"2015","journal-title":"AJR Am J Roentgenol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201803000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:00:34Z","timestamp":1689102034000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201803000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002474","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]}}}